List of Excipients in API auranofin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing auranofin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sebela Pharmaceuticals Inc | RIDAURA | auranofin | 54766-093 | BENZYL ALCOHOL | |
| Sebela Pharmaceuticals Inc | RIDAURA | auranofin | 54766-093 | CELLULOSE, MICROCRYSTALLINE | |
| Sebela Pharmaceuticals Inc | RIDAURA | auranofin | 54766-093 | CETYLPYRIDINIUM CHLORIDE | |
| Sebela Pharmaceuticals Inc | RIDAURA | auranofin | 54766-093 | D&C RED NO. 33 | |
| Sebela Pharmaceuticals Inc | RIDAURA | auranofin | 54766-093 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for auranofin
Excipient focus: BENZYL ALCOHOL
auranofin drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
auranofin drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYLPYRIDINIUM CHLORIDE
auranofin drug variants containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
auranofin drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
auranofin drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
auranofin drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
auranofin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
auranofin drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
auranofin drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
auranofin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
auranofin drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
auranofin drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
auranofin drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
auranofin drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
auranofin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sebela Pharmaceuticals Inc | auranofin | 54766-093 |
| Prometheus Laboratories Inc | auranofin | 65483-093 |
| >Company | >Ingredient | >NDC |
auranofin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
